Literature DB >> 2936373

Lack of effect of topical spironolactone on sebum excretion.

S Walton, W J Cunliffe, P Lookingbill, K Keczkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2936373     DOI： 10.1111/j.1365-2133.1986.tb02807.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  Hormonal treatment of acne in women.

Authors:  Tobechi L Ebede; Emily L Arch; Diane Berson
Journal:  J Clin Aesthet Dermatol       Date:  2009-12

2.  Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors:  Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

3.  Lack of endocrine systemic side effects after topical application of spironolactone in man.

Authors:  F O Rey; C Valterio; L Locatelli; A A Ramelet; J P Felber
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  Spironolactone for the treatment of acne in women, a retrospective study of 110 patients.

Authors:  J W Charny; J K Choi; W D James
Journal:  Int J Womens Dermatol       Date:  2017-03-13

5.  Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study.

Authors:  Azin Ayatollahi; Ansieh Samadi; Ayda Bahmanjahromi; Reza M Robati
Journal:  Health Sci Rep       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.